Stay updated on FGF401 in HCC and Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the FGF401 in HCC and Solid Tumors Clinical Trial page.

Latest updates to the FGF401 in HCC and Solid Tumors Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page revision/version indicator at the bottom was updated from v3.5.2 to v3.5.3, reflecting a site software release rather than a change to the study record content.SummaryDifference0.0%

- Check16 days agoChange DetectedPage revision updated to v3.5.2, replacing the previous v3.5.0 revision.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check45 days agoChange DetectedResources were updated to include Hepatocellular carcinoma and the Genetic and Rare Diseases Information Center, and the page revision was updated from v3.4.3 to v3.5.0.SummaryDifference0.2%

- Check60 days agoChange DetectedRevision history updated to v3.4.3; v3.4.2 was removed.SummaryDifference0.0%

- Check74 days agoChange DetectedPage layout and navigation appear updated; no core study data (eligibility criteria, endpoints, locations, or results) is visibly changed.SummaryDifference0.0%

- Check81 days agoChange DetectedThe page now displays Revision: v3.4.2, replacing Revision: v3.4.1.SummaryDifference0.0%

Stay in the know with updates to FGF401 in HCC and Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FGF401 in HCC and Solid Tumors Clinical Trial page.